Associated Banc-Corp’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-290
Closed -$4K 735
2020
Q4
$4K Hold
290
﹤0.01% 568
2020
Q3
$4K Hold
290
﹤0.01% 489
2020
Q2
$3K Hold
290
﹤0.01% 542
2020
Q1
$2K Buy
+290
New +$2.42K ﹤0.01% 661

Other funds holding RDY

Associated Banc-Corp's RDY Position: Q1 2021 in Review

Associated Banc-Corp sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 290 shares — an estimated $4K sold.

Associated Banc-Corp first reported a position in RDY in Q1 2020 and held it in 4 quarters. The position peaked at $4K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

  • Associated Banc-Corp reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 290 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $4K.
  • Associated Banc-Corp first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Dr. Reddy's Laboratories position peaked at $4K in Q4 2020.
  • 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.